Global Antibiotic Resistance Market Size, Trends & Analysis - Forecasts to 2026

Global Antibiotic Resistance Market Size, Trends & Analysis - Forecasts to 2026

By Disease (Complicated Urinary Tract Infection (cUTI), Acute Bacterial Skin and Skin Structure Infections (ABSSSI), Hospital Acquired Bacterial Pneumonia/Ventilator (HABP/VABP), Community Acquired Bacterial Pneumonia (CABP), Complicated Intra-Abdominal Infections (cIAI), Blood Stream Infections (BSI), Clostridium difficile infections (CDI)), By Drug Class (Lipoglycopeptides, Oxazolidinones, Cephalosporins, Tetracyclines, Combination, Others), By Pathogen (Acinetobacter baumannii (Carbapenem-Resistant), Pseudomonas aeruginosa (Carbapenem-Resistant), Staphylococcus Aureus (Methicillin-Resistant), E. coli/K. pneumoniae (Carbapenem-Resistant), Streptococcus pneumoniae (Penicillin-Non-Susceptible), Clostridium difficile (Cephalosporin-Resistant, Tetracycline-Resistant), Enterococcus faecium (Vancomycin-Resistant), Haemophilus Influenzae (Ampicillin-Resistant)), By Region (North America, Europe, Asia Pacific and Rest of the World); Vendor Landscape, End User Landscape and Company Market Share Analysis & Competitor Analysis

Antibiotic Resistance Market: Insights

The global antibiotic resistance market is estimated to witness a significant CAGR during the forecast period (2020-2026). Growing number of antibiotic-resistant infections along with the growing R&D activities in the pharmaceutical & biotechnology sectors are expected to increase the demand for antibiotic resistance.

 

Request a free sample copy of the report @https://www.globalmarketestimates.com/market-report/global-antibiotic-resistance-market-2057

Antibiotic Resistance Market: By Disease

On the basis of type, the global antibiotic resistance market is segmented into complicated urinary tract infection (cUTI), acute bacterial skin and skin structure infections (ABSSSI), hospital acquired bacterial pneumonia/ventilator (HABP/VABP), community acquired bacterial pneumonia (CABP), complicated intra-abdominal infections (cIAI), blood stream infections (BSI), and clostridium difficile infections (CDI)), among others. The report contains quantitative insights about the following:

1.1.  Introduction  

1.1.1.     Antibiotic Resistance Market, By Disease, 2020-2026 (USD Million)         

1.2.  Complicated Urinary Tract Infection (cUTI)   

1.2.1.  Complicated Urinary Tract Infection (cUTI) : Antibiotic Resistance Market, 2020-2026 (USD Million)

1.3.  Acute Bacterial Skin and Skin Structure Infections (ABSSSI)         

1.3.1.     Acute Bacterial Skin and Skin Structure Infections (ABSSSI): Antibiotic Resistance Market, 2020-2026 (USD Million)

1.4.  Hospital Acquired Bacterial Pneumonia/Ventilator (HABP/VABP)  

1.4.1.     Hospital Acquired Bacterial Pneumonia/Ventilator (HABP/VABP): Antibiotic Resistance Market, 2020-2026 (USD Million)

1.5.  Community Acquired Bacterial Pneumonia (CABP) 

1.5.1.     Community Acquired Bacterial Pneumonia (CABP): Antibiotic Resistance Market, 2020-2026 (USD Million)

1.6.  Complicated Intra-Abdominal Infections (cIAI)        

1.6.1.     Complicated Intra-Abdominal Infections (cIAI): Antibiotic Resistance Market, 2020-2026 (USD Million)

1.7.  Clostridium difficile infections (CDI)

1.7.1.     Clostridium difficile infections (CDI): Antibiotic Resistance Market, 2020-2026 (USD Million)

 

 

1.8.  Blood Stream Infections (BSI)          

1.8.1.     Blood Stream Infections (BSI): Antibiotic Resistance Market, 2020-2026 (USD Million)

1.9.  Others           

1.9.1.     Others: Antibiotic Resistance Market, 2020-2026 (USD Million)

Antibiotic Resistance Market: By Drug Class

On the basis of end-user, the global antibiotic resistance market is segmented into lipoglycopeptides, oxazolidinones, tetracyclines, combination, and cephalosporins, among others. The report contains quantitative insights about the following:

1.1.  Introduction  

1.1.1.     Antibiotic Resistance Market, By Drug Class, 2020-2026 (USD Million)     

1.2.  Lipoglycopeptides    

1.2.1.     Lipoglycopeptides: Antibiotic Resistance Market, 2020-2026 (USD Million)          

1.3.  Oxazolidinones         

1.3.1.     Oxazolidinones: Antibiotic Resistance Market, 2020-2026 (USD Million)

1.4.  Cephalosporins         

1.4.1.     Cephalosporins: Antibiotic Resistance Market, 2020-2026 (USD Million)

1.5.  Tetracyclines 

1.5.1.     Tetracyclines: Antibiotic Resistance Market, 2020-2026 (USD Million)

1.6.  Combination 

1.6.1.     Combination: Antibiotic Resistance Market, 2020-2026 (USD Million)

1.7.  Others           

1.7.1.     Others: Antibiotic Resistance Market, 2020-2026 (USD Million)

 

Antibiotic Resistance Market: By Pathogen

On the basis of pathogen, the global antibiotic resistance market is segmented into acinetobacter baumannii (carbapenem-resistant), pseudomonas aeruginosa (carbapenem-resistant), staphylococcus aureus (methicillin-resistant), e. coli/k. pneumoniae (carbapenem-resistant),

streptococcus pneumoniae (penicillin-non-susceptible), clostridium difficile (cephalosporin-resistant, tetracycline-resistant), enterococcus faecium (vancomycin-resistant), and haemophilus influenzae (ampicillin-resistant), among others. The report contains quantitative insights about the following:

 

 

1.1.  Introduction  

1.1.1.     Antibiotic Resistance Market, By Pathogen, 2020-2026 (USD Million)       

1.2.  Acinetobacter baumannii (Carbapenem-Resistant) 

1.2.1.     Acinetobacter baumannii (Carbapenem-Resistant): Antibiotic Resistance Market, 2020-2026 (USD Million)   

1.3.  Pseudomonas aeruginosa (Carbapenem-Resistant)

1.3.1.     Pseudomonas aeruginosa (Carbapenem-Resistant): Antibiotic Resistance Market, 2020-2026 (USD Million)

1.4.  Staphylococcus Aureus (Methicillin-Resistant)        

1.4.1.     Staphylococcus Aureus (Methicillin-Resistant): Antibiotic Resistance Market, 2020-2026 (USD Million)

1.5.  E. coli/K. pneumoniae (Carbapenem-Resistant)      

1.5.1.     E. coli/K. pneumoniae (Carbapenem-Resistant): Antibiotic Resistance Market, 2020-2026 (USD Million)

1.6.  Streptococcus pneumoniae (Penicillin-Non-Susceptible)    

1.6.1.     Streptococcus pneumoniae (Penicillin-Non-Susceptible): Antibiotic Resistance Market, 2020-2026 (USD Million)

1.7.  Clostridium difficile (Cephalosporin-Resistant, Tetracycline-Resistant)     

1.7.1.     Clostridium difficile (Cephalosporin-Resistant, Tetracycline-Resistant): Antibiotic Resistance Market, 2020-2026 (USD Million)

1.8.  Enterococcus faecium (Vancomycin-Resistant)       

1.8.1.     Enterococcus faecium (Vancomycin-Resistant): Antibiotic Resistance Market, 2020-2026 (USD Million)

1.9.  Haemophilus Influenzae (Ampicillin-Resistant)       

1.9.1.     Haemophilus Influenzae (Ampicillin-Resistant): Antibiotic Resistance Market, 2020-2026 (USD Million)

Antibiotic Resistance Market: By Region

On the basis of region, the global antibiotic resistance market is segmented into North America, Europe, Asia Pacific, Central & South America and Middle East & Africa. The countries covered include: U.S., Canada, Mexico, Germany, France, UK, Italy, Spain, China, India, Japan, South Korea, Australia, Brazil, Saudi Arabia, UAE, and South Africa among others. The report provides qualitative & quantitative insights both at a regional as well as country level.

1.1.  Introduction  

1.1.1.     Global Antibiotic Resistance Market, Regional Analysis, 2020-2026(USD Million)

 

1.2.  North America          

1.2.1.     North America Antibiotic Resistance Market, Regional Analysis, 2020-2026(USD Million)           

1.2.1.1.          By Disease     

1.2.1.1.1.                North America Antibiotic Resistance Market, By Disease, 2020-2026(USD Million)          

1.2.1.2.          By Drug Class 

1.2.1.2.1.                North America Antibiotic Resistance Market, By Drug Class, 2020-2026(USD Million)          

1.2.1.3.          By Pathogen   

1.2.1.3.1.                North America Antibiotic Resistance Market, By Pathogen, 2020-2026(USD Million)          

1.2.1.4.          By Country      

1.2.1.4.1.                U.S      

1.2.1.4.1.1.                     By Disease     

1.2.1.4.1.1.1.   U.S. Antibiotic Resistance Market, By Disease, 2020-2026(USD Million)   

1.2.1.4.1.2.                     By Drug Class 

1.2.1.4.1.2.1.   U.S. Antibiotic Resistance Market, By Drug Class, 2020-2026(USD Million)     

1.2.1.4.1.3.                     By Pathogen   

1.2.1.4.1.3.1.   U.S. Antibiotic Resistance Market, By Pathogen, 2020-2026(USD Million)

1.2.1.4.2.                Canada.          

1.2.1.4.2.1.                     By Disease     

1.2.1.4.2.1.1.   Canada Antibiotic Resistance Market, By Disease, 2020-2026(USD Million)     

1.2.1.4.2.2.                     By Drug Class 

1.2.1.4.2.2.1.   Canada Antibiotic Resistance Market, By Drug Class, 2020-2026(USD Million)     

1.2.1.4.2.3.                     By Pathogen   

1.2.1.4.2.3.1.   Canada Antibiotic Resistance Market, By Pathogen, 2020-2026(USD Million)     

1.2.1.4.3.                Mexico

1.2.1.4.3.1.                     By Disease     

1.2.1.4.3.1.1.   Mexico Antibiotic Resistance Market, By Disease, 2020-2026(USD Million)     

1.2.1.4.3.2.                     By Drug Class 

1.2.1.4.3.2.1.   Mexico Antibiotic Resistance Market, By Drug Class, 2020-2026(USD Million)     

1.2.1.4.3.3.                     By Pathogen   

1.2.1.4.3.3.1.   Mexico Antibiotic Resistance Market, By Pathogen, 2020-2026(USD Million)     

1.3.  Europe           

1.3.1.     Europe Antibiotic Resistance Market, Regional Analysis, 2020-2026(USD Million)           

1.3.1.1.          By Disease     

1.3.1.1.1.                Europe Antibiotic Resistance Market, By Disease, 2020-2026(USD Million)          

1.3.1.2.          By Drug Class 

1.3.1.2.1.                Europe Antibiotic Resistance Market, By Drug Class, 2020-2026(USD Million)     

1.3.1.3.          By Pathogen   

1.3.1.3.1.                Europe Antibiotic Resistance Market, By Pathogen, 2020-2026(USD Million)       

1.3.1.4.          By Country      

1.3.1.4.1.                Germany        

1.3.1.4.1.1.                     By Disease     

1.3.1.4.1.1.1.   Germany Antibiotic Resistance Market, By Disease, 2020-2026(USD Million)     

1.3.1.4.1.2.                     By Drug Class 

1.3.1.4.1.2.1.   Germany Antibiotic Resistance Market, By Drug Class, 2020-2026(USD Million)     

1.3.1.4.1.3.                     By Pathogen   

1.3.1.4.1.3.1.   Germany Antibiotic Resistance Market, By Pathogen, 2020-2026(USD Million)     

1.3.1.4.2.                UK       

1.3.1.4.2.1.                     By Disease     

1.3.1.4.2.1.1.   UK Antibiotic Resistance Market, By Disease, 2020-2026(USD Million)     

1.3.1.4.2.2.                     By Drug Class 

1.3.1.4.2.2.1.   UK Antibiotic Resistance Market, By Drug Class, 2020-2026(USD Million)

1.3.1.4.2.3.                     By Pathogen   

1.3.1.4.2.3.1.   UK Antibiotic Resistance Market, By Pathogen, 2020-2026(USD Million)  

1.3.1.4.3.                France

1.3.1.4.3.1.                     By Disease     

1.3.1.4.3.1.1.   France Antibiotic Resistance Market, By Disease, 2020-2026(USD Million)     

1.3.1.4.3.2.                     By Drug Class 

1.3.1.4.3.2.1.   France Antibiotic Resistance Market, By Drug Class, 2020-2026(USD Million)     

1.3.1.4.3.3.                     By Pathogen   

1.3.1.4.3.3.1.   France Antibiotic Resistance Market, By Pathogen, 2020-2026(USD Million)     

1.3.1.4.4.                Italy    

1.3.1.4.4.1.                     By Disease     

1.3.1.4.4.1.1.   Italy Antibiotic Resistance Market, By Disease, 2020-2026(USD Million)  

1.3.1.4.4.2.                     By Drug Class 

1.3.1.4.4.2.1.   Italy Antibiotic Resistance Market, By Drug Class, 2020-2026(USD Million)     

1.3.1.4.4.3.                     By Pathogen   

1.3.1.4.4.3.1.   Italy Antibiotic Resistance Market, By Pathogen, 2020-2026(USD Million)

 

1.4.  Asia Pacific   

1.4.1.     Asia Pacific Antibiotic Resistance Market, Regional Analysis, 2020-2026(USD Million)   

1.4.1.1.          By Disease     

1.4.1.1.1.                Asia Pacific Antibiotic Resistance Market, By Disease, 2020-2026(USD Million)  

1.4.1.2.          By Drug Class 

1.4.1.2.1.                Asia Pacific Antibiotic Resistance Market, By Drug Class, 2020-2026(USD Million)                      

1.4.1.3.          By Pathogen   

1.4.1.3.1.                Asia Pacific Antibiotic Resistance Market, By Pathogen, 2020-2026(USD Million)

1.4.1.4.          By Country      

1.4.1.4.1.                China  

1.4.1.4.1.1.                     By Disease     

1.4.1.4.1.1.1.   China Antibiotic Resistance Market, By Disease, 2020-2026(USD Million)

1.4.1.4.1.2.                     By Drug Class 

1.4.1.4.1.2.1.   China Antibiotic Resistance Market, By Drug Class, 2020-2026(USD Million)     

1.4.1.4.1.3.                     By Pathogen   

1.4.1.4.1.3.1.   China Antibiotic Resistance Market, By Pathogen, 2020-2026(USD Million)     

1.4.1.4.2.                Japan  

1.4.1.4.2.1.                     By Disease     

1.4.1.4.2.1.1.   Japan Antibiotic Resistance Market, By Disease, 2020-2026(USD Million)

1.4.1.4.2.2.                     By Drug Class 

1.4.1.4.2.2.1.   Japan Antibiotic Resistance Market, By Drug Class, 2020-2026(USD Million)     

1.4.1.4.2.3.                     By Pathogen   

1.4.1.4.2.3.1.   Japan Antibiotic Resistance Market, By Pathogen, 2020-2026(USD Million)     

1.4.1.4.3.                India   

1.4.1.4.3.1.                     By Disease     

1.4.1.4.3.1.1.   India Antibiotic Resistance Market, By Disease, 2020-2026(USD Million) 

1.4.1.4.3.2.                     By Drug Class 

1.4.1.4.3.2.1.   India Antibiotic Resistance Market, By Drug Class, 2020-2026(USD Million)     

1.4.1.4.3.3.                     By Pathogen   

1.4.1.4.3.3.1.   India Antibiotic Resistance Market, By Pathogen, 2020-2026(USD Million)     

1.4.1.4.4.                South Korea   

1.4.1.4.4.1.                     By Disease     

1.4.1.4.4.1.1.   South Korea Antibiotic Resistance Market, By Disease, 2020-2026(USD Million)     

1.4.1.4.4.2.                     By Drug Class 

1.4.1.4.4.2.1.   South Korea Antibiotic Resistance Market, By Drug Class, 2020-2026(USD Million)     

1.4.1.4.4.3.                     By Pathogen   

1.4.1.4.4.3.1.   South Korea Antibiotic Resistance Market, By Pathogen, 2020-2026(USD Million)

1.4.1.4.5.                Rest Of Apac  

1.4.1.4.5.1.                     By Disease     

1.4.1.4.5.1.1.   Rest Of Apac, Antibiotic Resistance Market, By Disease, 2020-2026(USD Million)     

1.4.1.4.5.2.                     By Drug Class 

1.4.1.4.5.2.1.   Rest Of Apac Antibiotic Resistance Market, By Drug Class, 2020-2026(USD Million)     

1.4.1.4.5.3.                     By Pathogen   

Rest Of Apac Antibiotic Resistance Market, By Pathogen, 2020-2026(USD Million)

1.5.  Central & South America     

1.5.1.     Central & South America Antibiotic Resistance Market, Regional Analysis, 2020-2026(USD Million)   

1.5.1.1.          By Disease     

1.5.1.1.1.                Central & South America Antibiotic Resistance Market, By Disease, 2020-2026(USD Million)          

1.5.1.2.          By Drug Class 

1.5.1.2.1.                Central & South America Antibiotic Resistance Market, By Drug Class, 2020-2026(USD Million)                

1.5.1.3.          By Pathogen   

1.5.1.3.1.                Central & South America Antibiotic Resistance Market, By Pathogen, 2020-2026(USD Million)    

1.5.1.4.          By Country      

1.5.1.4.1.                Brazil  

1.5.1.4.1.1.                     By Disease     

1.5.1.4.1.1.1.   Brazil Antibiotic Resistance Market, By Disease, 2020-2026(USD Million)

1.5.1.4.1.2.                     By Drug Class 

1.5.1.4.1.2.1.   Brazil Antibiotic Resistance Market, By Drug Class, 2020-2026(USD Million)     

1.5.1.4.1.3.                     By Pathogen   

1.5.1.4.1.3.1.   Brazil Antibiotic Resistance Market, By Pathogen, 2020-2026(USD Million)     

1.6.  Middle East & Africa 

1.6.1.     Middle East & Africa Antibiotic Resistance Market, Regional Analysis, 2020-2026(USD Million) 

1.6.1.1.          By Disease     

1.6.1.1.1.                Middle East & Africa Antibiotic Resistance Market, By Disease, 2020-2026(USD Million)          

1.6.1.2.          By Drug Class 

1.6.1.2.1.                Middle East & Africa Antibiotic Resistance Market, By Drug Class, 2020-2026(USD Million)          

1.6.1.3.          By Pathogen   

1.6.1.3.1.                Middle East & Africa Antibiotic Resistance Market, By Pathogen, 2020-2026(USD Million)          

1.6.1.4.          By Country      

1.6.1.4.1.                Saudi Arabia  

1.6.1.4.1.1.                     By Disease     

1.6.1.4.1.1.1.   Saudi Arabia Antibiotic Resistance Market, By Disease, 2020-2026(USD Million)     

1.6.1.4.1.2.                     By Drug Class 

1.6.1.4.1.2.1.   Saudi Arabia Antibiotic Resistance Market, By Drug Class, 2020-2026(USD Million)     

1.6.1.4.1.3.                     By Pathogen   

1.6.1.4.1.3.1.   Saudi Arabia Antibiotic Resistance Market, By Pathogen, 2020-2026(USD Million)     

1.6.1.4.2.                UAE     

1.6.1.4.2.1.                     By Disease     

1.6.1.4.2.1.1.   UAE Antibiotic Resistance Market, By Disease, 2020-2026(USD Million)   

1.6.1.4.2.2.                     By Drug Class 

1.6.1.4.2.2.1.   UAE Antibiotic Resistance Market, By Drug Class, 2020-2026(USD Million)     

1.6.1.4.2.3.                     By Pathogen   

1.6.1.4.2.3.1.   UAE Antibiotic Resistance Market, By Pathogen, 2020-2026(USD Million) 

Antibiotic Resistance Market: End Use Landscape

The end-user landscape entails a list of current and prospective consumers prevailing across the regions. This section briefs you about company addresses, contact details, products, and regional presence of companies who are purchasing or are likely to purchase antibiotic resistance. The key end-users of the markets are Chang Gung Memorial Hospital and Mayo Clinic, among others.

Antibiotic Resistance Market: Vendor Landscape

The report contains a chapter dedicated to vendors operating in the market, covering raw material manufactures, equipment developers, manufacturers, and distributors. The report provides these insights on a regional level. This section of the report entails contact details, experience, products manufactured/supplied, and geographical presence of companies.

Antibiotic Resistance Market: Share & Competitor Analysis

Some of the key players operating in the antibiotic resistance market are Basilea Pharmaceutica Ltd., Melinta Therapeutics, Tetraphase Pharmaceuticals, Inc., Theravance Biopharma, Inc., Wockhardt therapeutics, Entasis Therapeutics, PARATEK Therapeutics, and Seres Therapeutics, Inc., among others.

 

Browse the report @https://www.globalmarketestimates.com/market-report/global-antibiotic-resistance-market-2057